Working at Nabriva
Nabriva has experienced teams working on commercializing Xenleta™(lefamulin) and preparing for the potential launch of CONTEPO™ (fosfomycin for injection.) In addition, we have dedicated professionals focused on research and development, from early discovery through preclinical and clinical development of novel antibiotics. In addition to working alongside our highly experienced team members, we offer the dynamic and flexible culture of a biotechnology company.
We invite you to browse our current openings below.